|Bid||14.80 x 200|
|Ask||15.50 x 800|
|Day's Range||14.92 - 16.17|
|52 Week Range||11.30 - 19.20|
|PE Ratio (TTM)||-16.12|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||35.50|
Q1 2017 Arena Pharmaceuticals Inc Earnings Call
Will this CB2 receptor agonist designed to treat pain put Arena on investors' radars?
Arena Pharmaceuticals (ARNA) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.